Please Wait.....
Report
Global Cartilage Repair/Regeneration - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 115 Pages I Mordor Intelligence
Global Cartilage Repair/Regeneration Market Analysis
The cartilage repair market is valued at USD 1.73 billion in 2025 and is on course to reach USD 3.28 billion by 2030, translating into a 13.7% CAGR. Demographic aging, rising obesity, and sports injury volumes expand the patient pool, while technological advances in cell-based implants and tissue-engineered scaffolds improve clinical outcomes. Outpatient arthroscopic procedures shorten recovery times and lower costs, reinforcing payer and provider adoption. North America leads revenue generation, but Asia-Pacific posts the fastest expansion as healthcare infrastructure and disposable incomes climb. Competitive activity is steady, with large device firms acquiring niche innovators to secure next-generation technologies.
Global Cartilage Repair/Regeneration Market Trends and Insights
Escalating Global Incidence of Osteoarthritis and Traumatic Cartilage Lesions
Surging osteoarthritis prevalence, which climbed 132.2% between 1990 and 2022, now affects 7.96% of the global population and drives sustained demand for restorative surgery. Adult cases aged 30-44 exceeded 32.97 million in 2022, underscoring a shift toward younger patients seeking durable repair solutions. Chondral defects afflict 36% of athletes' knees, creating a sizable cohort that prefers definitive intervention over symptom management . The widening patient base ensures that the cartilage repair market remains on an expanding trajectory through the decade.
Surge in Outpatient Minimally Invasive Orthopedic Procedures
Same-day discharge for joint surgeries in the United States rose from less than 1% in 2017 to 30.5% in 2023, demonstrating payer and provider confidence in ambulatory pathways. FDA clearance of MACI Arthro in August 2024 validated arthroscopic delivery of autologous chondrocyte implants, further normalizing outpatient treatment. Ambulatory surgical centers benefit most, displaying a 15.07% CAGR through 2030 as they combine cost savings with better patient convenience. This procedural migration underpins broader adoption across the cartilage repair market.
High Procedure and Implant Costs Limiting Uptake
Stem-cell knee therapy costs range between USD 5,000 and USD 15,000 in South Korea, restricting adoption beyond affluent or insured patients. China's volume-based procurement cut total hip arthroplasty prices by 50.1%, highlighting intense cost pressure that could spill over to cartilage technologies. Blue Cross payers in the United States mandate stringent criteria for autologous chondrocyte implantation, illustrating reimbursement hurdles. These economic constraints slow penetration in price-sensitive regions, tempering cartilage repair market growth.
Other drivers and restraints analyzed in the detailed report include:
Breakthroughs in Tissue-Engineered Scaffolds and Cell-Based Implants / Increasing Participation in High-Impact and Recreational Sports / Lengthy and Complex Regulatory Approval Pathways /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Hyaline tissue held 66.14% of revenue in 2024, confirming its central role in load-bearing joints most vulnerable to degeneration. Bilayer atelocollagen scaffolds now replicate hyaline morphology more reliably, improving long-term outlook for patients. Fibrocartilage, driven by meniscal repair needs, is projected to expand at 14.45% CAGR, supported by advances in collagen-based hydrogels that recruit endogenous stem cells.
The cartilage repair market size for hyaline applications is projected to widen further as surgeons prioritize tissue-specific products that enhance integration. Meanwhile, niche elastic-cartilage reconstruction for ear and nasal defects creates incremental volume, diversifying revenue streams across smaller sub-segments.
Cell-based solutions captured 62.39% revenue in 2024 through clinical superiority in pain reduction and tissue restoration, as evidenced by meta-analysis reporting standardized mean differences of -1.27 in pain scores . However, cell-free implants should post 14.69% CAGR through 2030 on the strength of off-the-shelf availability and lower cost.
Premium products such as MACI generated USD 46.3 million in Q1 2025 sales, reflecting commercial traction in the United States. Conversely, CARTIHEAL Agili-C offers a cell-free scaffold that reduced total knee arthroplasty risk by 87% at four years. Healthy rivalry between personalized and ready-to-use solutions ensures a balanced growth outlook across the cartilage repair market.
The Cartilage Repair Market Report is Segmented by Types of Cartilage (Hyaline, and More), Treatment Modality (Cell-Based, Non-cell-based/Cell-free), Treatment Type (Palliative, and More), Surgical Technique (ACI, and More), Application Site (Knee, Hip, and More), End User (Hospitals & Clinics, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America produced 45.15% of 2024 revenue, underpinned by FDA clearances and consistent private?payer reimbursement. Vericel, Arthrex, and Stryker dominate surgeon preference, while Johnson & Johnson's VELYS unicompartmental knee robot received clearance in June 2024, spotlighting ongoing innovation. Growth remains steady as baby-boomer activity levels sustain procedure volumes.
Asia-Pacific is projected to deliver a 15.64% CAGR, buoyed by infrastructure investment and rising disposable incomes. China's procurement reforms, which halved implant prices, improve affordability even as regulatory pathways tighten. Japan leverages universal coverage for advanced therapies, whereas South Korea attracts inbound medical tourists for stem-cell knee repairs priced at USD 5,000-15,000. India's expanding middle class gradually lifts procedure counts despite reimbursement gaps.
Europe sustains innovation momentum through EMA's advanced therapy framework and EUR 11.3 million ENCANTO funding. Middle East & Africa and South America remain nascent yet compelling as economic development enlarges insured populations, positioning them as long-range demand reservoirs for the cartilage repair market.
List of Companies Covered in this Report:
Arthrex / Stryker / Zimmer Biomet / Smiths Group / Johnson&Johnson / Vericel / Anika Therapeutics / B. Braun / Geistlich Pharma / CYFUSE Biomedical K.K. / Conmed / MEDIPOST / CartiHeal Ltd. / Askel Healthcare Oy / BioTissue / Collagen Solutions / Matricel / Orthocell Ltd. / Osiris Therapeutics / Autocart Inc. /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Escalating Global Incidence Of Osteoarthritis And Traumatic Cartilage Lesions
4.2.2 Surge In Outpatient Minimally Invasive Orthopedic Procedures
4.2.3 Breakthroughs In Tissue-Engineered Scaffolds And Cell-Based Implants
4.2.4 Increasing Participation In High-Impact And Recreational Sports, Elevating Injury Volumes That Require Cartilage Repair
4.2.5 Increasing Reimbursement Coverage For Biologic Knee Restoration Across Major Markets
4.2.6 Expanding Participation In High-Impact Sports Raising Injury Volumes
4.3 Market Restraints
4.3.1 High Procedure And Implant Costs Limiting Uptake In Price-Sensitive Regions
4.3.2 Lengthy And Complex Regulatory Approval Pathways For Advanced Therapies
4.3.3 Limited Long-Term Clinical Durability Data Curbing Surgeon Confidence
4.3.4 Supply Constraints Of Qualified Donor Tissue And Gmp Manufacturing Capacity
4.4 Value / Supply-Chain Analysis
4.5 Regulatory & Technological Outlook
4.6 Porter's Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitutes
4.6.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Types of Cartilage
5.1.1 Hyaline Cartilage
5.1.2 Fibrocartilage
5.1.3 Elastic / Other Cartilage
5.2 By Treatment Modality
5.2.1 Cell-based Therapies
5.2.2 Non-cell-based / Cell-free Therapies
5.3 By Treatment Type
5.3.1 Palliative (Debridement, Viscosupplementation)
5.3.2 Intrinsic Repair Stimulus (ACI, MACI, Micro-fracture)
5.4 By Surgical Technique
5.4.1 Chondroplasty & Micro-fracture
5.4.2 Autologous Chondrocyte Implantation (ACI)
5.4.3 Matrix-induced ACI (MACI)
5.4.4 Osteochondral Allograft / Juvenile Allograft
5.5 By Application Site
5.5.1 Knee
5.5.2 Hip
5.5.3 Ankle
5.5.4 Spine
5.5.5 Other Joints (Shoulder, Elbow, Wrist)
5.6 By End User
5.6.1 Hospitals & Clinics
5.6.2 Ambulatory Surgical Centers
5.7 By Geography
5.7.1 North America
5.7.1.1 United States
5.7.1.2 Canada
5.7.1.3 Mexico
5.7.2 Europe
5.7.2.1 Germany
5.7.2.2 United Kingdom
5.7.2.3 France
5.7.2.4 Italy
5.7.2.5 Spain
5.7.2.6 Rest of Europe
5.7.3 Asia-Pacific
5.7.3.1 China
5.7.3.2 Japan
5.7.3.3 India
5.7.3.4 Australia
5.7.3.5 South Korea
5.7.3.6 Rest of Asia-Pacific
5.7.4 Middle East & Africa
5.7.4.1 GCC
5.7.4.2 South Africa
5.7.4.3 Rest of Middle East & Africa
5.7.5 South America
5.7.5.1 Brazil
5.7.5.2 Argentina
5.7.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Arthrex Inc.
6.3.2 Stryker
6.3.3 Zimmer Biomet
6.3.4 Smith + Nephew
6.3.5 Johnson & Johnson (DePuy Synthes)
6.3.6 Vericel Corporation
6.3.7 Anika Therapeutics Inc.
6.3.8 B. Braun SE
6.3.9 Geistlich Pharma AG
6.3.10 CYFUSE Biomedical K.K.
6.3.11 Conmed Corporation
6.3.12 MEDIPOST
6.3.13 CartiHeal Ltd.
6.3.14 Askel Healthcare Oy
6.3.15 BioTissue
6.3.16 Collagen Solutions PLC
6.3.17 Matricel GmbH
6.3.18 Orthocell Ltd.
6.3.19 Osiris Therapeutics
6.3.20 Autocart Inc.
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security